Metraipolis › archive › dc_ea73b55a12ce
Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program — Europe PMC PMID:42251748
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42251748
- DOI
- 10.1093/ijnp/pyag029
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T13:57:38.697Z
- SHA-256 of the archived text
bfd342f30a10b27dd1ac33764a2dd7e6a2aa56b7cd35f9949fd853f4ab249fe9- Stable URL of this page
https://metraipolis.com/documento/dc_ea73b55a12ce
How to cite
Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program — Europe PMC PMID:42251748 — Europe PMC (en), https://europepmc.org/article/MED/42251748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea73b55a12ce (Metraipolis archive dc_ea73b55a12ce, sha256 bfd342f30a10b27dd1ac33764a2dd7e6a2aa56b7cd35f9949fd853f4ab249fe9)
BibTeX
@misc{dcea73b55a12ce,
title = {Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program — Europe PMC PMID:42251748},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42251748},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea73b55a12ce; sha256 bfd342f30a10b27dd1ac33764a2dd7e6a2aa56b7cd35f9949fd853f4ab249fe9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42251748. Agents can read the archived copy with the MCP tool read_document.